News | Remington Davis

Category:

All Categories

From Protocol to Prediction: AI in Clinical Trial Design

May 21st, 2026 in Glossary

Clinical research has always been defined by two competing pressures: the need for scientific rigor and the reality of human complexity. Every trial must be tight enough to produce defensible evidence and flexible enough to handle contact with real patients, real sites, and a[...]

AI in Clinical Trial Patient Recruitment: A Practical Guide for Sponsors and CROs

May 14th, 2026 in Glossary

Recruitment has always been central to clinical trial success, but it's being approached in new and novel ways. Artificial intelligence is now being applied across the recruitment lifecycle, helping sponsors and sites move beyond manual, reactive processes toward more targeted[...]

The Charged Silence of the Iron Lung

May 7th, 2026 in Vaccines

Every symphony begins before the first note is ever played. That's how Dr. Gregory A. Poland, Director of the Mayo Vaccine Research Group at Mayo Clinic, opened his keynote at the 2026 World Vaccine Congress—with charged silence. Not the silence of absence, but the kind that[...]

Clinical Trial Timelines Keep Getting Longer. What Needs to Change?

Apr 15th, 2026 in Trends

In 2020, theaverage clinical trial cyclewas 93.4 months. By 2024, it jumped to 100.4 months. Seven plus months. In the context of new drug development, where every month carries a sizable financial cost and time patients spend waiting for treatments, that time increase is[...]

AI’s Benefits in Clinical Trial Data Analysis & How To Implement It Safely

Apr 7th, 2026 in Glossary

Clinical trial data analysis determines whether research produces clear, reliable conclusions. Every endpoint evaluation, safety assessment, and regulatory submission depends on the ability to precisely interpret complex clinical datasets. As clinical trials grow more[...]

Improving Patient Access to Clinical Trials: How Community-Based Healthcare Networks Expand Participation

Mar 31st, 2026 in Enrollment

Clinical trials depend on the ability to connect the right patients with the right studies. Yet across the research industry, identifying eligible participants is becoming increasingly complex. That’s whyimproving patient access to clinical trials is a top priority for clinical[...]

Clinical Trial Design By AI: Benefits, Risks & a Roadmap for Sponsors

Mar 24th, 2026 in Glossary

Artificial intelligence is being used to model feasibility, stress-test eligibility criteria, forecast recruitment performance, and identify potential clinical trial design weaknesses before a study launches. Done well, it sharpens planning. Done poorly, it simply scales flawed[...]

Clinical Trial Recruitment Strategies: The Local Healthcare Partnership Multiplier

Mar 10th, 2026 in Enrollment

Sponsors today have more tools than ever to support clinical trial recruitment strategies. Digital campaigns can reach highly specific audiences. Social platforms increase visibility. Hybrid models reduce participation burden and expand geographic flexibility. Yet patient[...]

How AI Accelerates Clinical Trial Processes

Feb 26th, 2026 in Glossary

Designing and executing a clinical trial involves a sequence of high-stakes decisions, each with its own potential to delay timelines. Whether it’s recruiting the right patients, managing multi-source data inputs, or preparing audit-ready documentation, delays can compound[...]

AI-Driven Solutions for Clinical Trial Efficiency

Feb 19th, 2026 in Glossary

Artificial intelligence is increasingly being used to improve efficiency across the clinical trial lifecycle. Rather than functioning as a single technology, AI encompasses multiple approaches that solve different operational challenges, from reducing administrative burden to[...]

Remington-Davis Forms Alliance with Central Ohio Primary Care to Expand Clinical Trial Access

Feb 11th, 2026 in News

Columbus, Ohio — Remington-Davis, Inc. (RDI), an independent clinical research site with over three decades of experience, is proud to announce a new strategic alliance with Central Ohio Primary Care (COPC), one of the nation’s largest physician-owned primary care organizations.

Remington-Davis Enters Strategic Partnership With Assured Clinical Research

Feb 2nd, 2026 in News

Remington-Davis, a leading clinical trial facility in Columbus, Ohio, is proud to announce a new strategic partnership with U.K.-based Assured Clinical Research, marking Assured’s first U.S. site collaboration. Assured Clinical Research is building a next-generation clinical[...]

6 Questions a Site Should Ask To Support Clinical Trial Protocol Optimization

Jan 29th, 2026 in Trial Design

Even the most well-designed protocols can encounter unexpected challenges once a trial is underway. Procedures that seem straightforward on paper may prove burdensome in practice. Eligibility criteria that appear reasonable may limit enrollment more than anticipated. Small[...]

From Delays to Amendments: The High Cost of Getting Clinical Trial Protocol Design Wrong

Jan 22nd, 2026 in Trial Design

Clinical trial success hinges on a strong foundation, and that foundation is protocol design. It’s the blueprint that guides everything from study startup and patient enrollment to data collection and final analysis. But what happens when that blueprint for conducting the trial[...]

AI’s Role in Clinical Trial Patient Selection

Jan 15th, 2026 in Glossary

Eligibility criteria for a clinical trial can contain dozens of variables, from lab results and diagnostic codes to comorbidities, medication histories, and other forms of medical data. For coordinators and investigators, that means poring through electronic health records[...]

AI in Vaccine Development: Opportunities, Challenges & the Human Element

Jan 8th, 2026 in Glossary

Vaccine development has seen remarkable breakthroughs over the past several years. The accelerated rollout of COVID-19 vaccines, particularly those using mRNA platforms, is a clear sign of just how far the field has advanced in terms of speed, precision, and global coordination.[...]

AI and Machine Learning in Clinical Trials: A Guide for Sponsors

Dec 10th, 2025 in Glossary

Artificial intelligence (AI) and machine learning (ML) have become an integral part of clinical trial operations. While these technologies are sometimes lumped together, their roles and functions are distinct yet complementary. This overview explores where we’re seeing the most[...]

Cost of Clinical Trials: Where Overspend Happens and How To Curb It

Dec 2nd, 2025 in Metrics

Conversation around healthcare costs often centers on drug prices. What tends to be overlooked is the cost of getting a drug to market in the first place. Clinical development continues to be one of the largest and most variable cost drivers in the entire drug lifecycle. A[...]

Artificial Intelligence’s Role & Impact in Clinical Data Management

Nov 18th, 2025 in Glossary

For decades, clinical data management (CDM) was built around linear, labor-intensive workflows. Teams manually reviewed case report forms, tracked down discrepancies, and cleaned data through rounds of queries and reconciliations. The process was reliable but slow, and with[...]

Advances in COPD Treatment: A New Chapter in a Long-Fought Battle

Nov 11th, 2025 in Pulmonary

Chronic obstructive pulmonary disease (COPD) remains a major public health concern in the United States. In 2021 alone, thedisease claimed more than 138,000 lives, making it the sixth leading cause of death overall and the fifth leading cause of death from disease. Yet amid[...]

The Promise and Limits of AI Clinical Trial Recruitment

Oct 28th, 2025 in Trends

In the past year, Cleveland Clinic has made headlines for its strategic adoption of artificial intelligence across multiple areas of care and operations, from AI-powered structural heart tools through DASI Simulations to AI-driven revenue cycle management via AKASA. But another[...]

Why Is Patient Education Important in Clinical Research?

Oct 16th, 2025 in Patient Experience

Clinical trials are designed to test new treatments, yet for participants, the experience can be just as much about learning. At Remington-Davis, we’ve found that when you prioritize patient education during a study, it not only supports retention and compliance; it also equips[...]

Long-Term Side Effects of Ozempic: What Clinical Researchers and Sponsors Should Know

Sep 30th, 2025 in Glossary

Ozempic (semaglutide) is a GLP-1 receptor agonist initially approved for managing type 2 diabetes and now also prescribed—under various brands—for chronic weight management. Its benefits are clinically meaningful: improved glycemic control, cardiovascular risk reduction, and[...]

A Higher Purpose: Reframing Clinical Trial Participation as Service

Sep 23rd, 2025 in Patient Experience

People join clinical trials for many reasons. Sometimes, it’s to access treatment that isn’t yet available through traditional care. Sometimes it’s out of a willingness to try something new when standard therapies no longer work. And sometimes, it’s out of a desire to simply[...]

A Practical Guide to Risk-Based Monitoring in Clinical Trials

Sep 16th, 2025 in Glossary

The pace and complexity of clinical trials continue to grow, along with the cost of inefficiencies. For some time now, conventional site monitoring has overly relied on resource-heavy routines that prioritize quantity over quality. But risk-based monitoring (RBM) has emerged as[...]

4 Areas to Assess Clinical Trial Site Performance

Sep 10th, 2025 in Metrics

Choosing the right clinical trial site is a critical decision for pharmaceutical companies, but it’s only the beginning. Once the trial begins, how do you know your site is truly performing? Sponsor confidence in trial performance can’t be based on gut feeling or good[...]

Automation in Clinical Trials: A Practical Framework for Faster, More Reliable Trials

Sep 3rd, 2025 in Glossary

As clinical trials evolve, so do the tools and technologies that support them. With increasing protocol complexity, decentralized and hybrid models, and demand for real-time data, sponsors and CROs need systems that enable consistency, accuracy, and speed across trial sites. [...]

The Five-Star Experience: Setting a New Standard for Patient-Centricity in Clinical Trials

Aug 12th, 2025 in Trends

Participating in a clinical trial is a big commitment. It’s a decision that often requires patients to rearrange their work schedules, find transportation, fast before appointments, or spend hours away from home, all while navigating unknowns common to treatment and research. [...]

COPD Clinical Study Recruitment: Why It’s Challenging & How To Streamline It

Aug 5th, 2025 in Immunology

Recruiting patients for any clinical trial presents challenges, but chronic obstructive pulmonary disease (COPD) clinical studies are especially difficult. From diagnostic gaps to physical limitations and socioeconomic barriers, the COPD patient population is one of the most[...]

The Rising Value of Clinical Trial Business Intelligence

Jul 29th, 2025 in Glossary

Clinical trials generate a tremendous volume of data. But what matters is the ability to draw timely, meaningful insights and act on them with confidence. Once used primarily for retrospective reporting, business intelligence (BI) now plays a central role in guiding decisions at[...]

FDA Job Cuts Could Disrupt Clinical Trials

Jul 24th, 2025 in Trends

Over the past several months, the Food and Drug Administration (FDA) has seen a wave of high-level departures and widespread staff reductions — part of a broader government effort to reduce the Department of Health and Human Services (HHS) workforce by 10,000 jobs. In April of[...]

Clinical Safety Data Management: How Sites Protect Patients and Maintain Trial Integrity

Jul 22nd, 2025 in Glossary

When a patient experiences an unexpected complication in a clinical trial, everything changes. Clinical safety data management—the structured process for documenting, evaluating, and reporting adverse events (AEs) and serious adverse events (SAEs)—is what guarantees those[...]

How Patient Recruitment Software for Pharma Trials Supports Site Success

Jul 15th, 2025 in Glossary

Recruiting patients for clinical trials remains one of the most resource-intensive and timeline-sensitive aspects of study execution. Even with increased awareness and decentralized trial models, many studies still face enrollment shortfalls that threaten data integrity and[...]

What Private Equity’s Rise in Clinical Research Means for Sites, Sponsors and Trial Outcomes

Jul 9th, 2025 in Trends

There has been a sharp uptick in recent years in private equity acquisitions of locally owned research sites. Backed by goals for greater scale and operational efficiency, these firms are assembling site networks that span geographies and specialties. But as this trend[...]

In the Age of AI, Patient-Centric Clinical Trials Must Stay Human at Heart

Jun 24th, 2025 in Trends

The future of clinical research is arriving faster than we imagined. With artificial intelligence now at the center of conversations between OpenAI and the FDA, the industry is on the cusp of a major transformation. There’s growing excitement about how AI could streamline drug[...]

eConsents: Modern Standard for Clinical Trial Consent

Jun 10th, 2025 in Glossary

Digital innovation has transformed the way clinical trials operate—and part of that is the informed consent process. eConsent, or electronic informed consent, is gaining traction as a standard for clinical research that prioritizes accessibility, compliance, and participant[...]

The Rise of Rare Disease Clinical Trials: Trends, Challenges and What Sites Are Learning

Jun 4th, 2025 in Trends

Rare diseases may affect only small pockets of the population, but in clinical research, they make an outsized impact. In fact, 45% of global trial starts in 2024 were focused on rare diseases, according to theIQVIA Global R&D Trends report. Once considered too specialized or[...]

Electronic Patient Reported Outcomes: Improving Data Accuracy and Patient Engagement

May 13th, 2025 in Glossary

In modern clinical trials, participant-reported data is essential for evaluating treatment safety, efficacy, and tolerability—especially in studies where symptoms, side effects, or quality of life play a central role. Electronic patient-reported outcomes (ePRO) systems[...]

Clinical Trial Data Visualization: Turning Complexity Into Clarity

May 6th, 2025 in Glossary

Clinical trials generate vast amounts of data, from patient demographics and laboratory results to device-captured metrics and adverse event reports. As trials increase in complexity, interpreting this data quickly and accurately has become essential. That’s where clinical trial[...]

The Real Cost of Cutting Funding for Vaccine Research

May 1st, 2025 in News

In a time when global public health still reels from the aftershocks of the COVID-19 pandemic, the U.S. is facing a new crisis — one that’s quieter but just as dangerous. Recent federal cuts to funding for vaccine research have sparked concern among medical experts, foreign[...]

From Compliance to Connection: Community Engagement For Clinical Trials

Apr 24th, 2025 in Trends

As pressure grows for clinical research to be more representative, one thing is becoming increasingly clear: true inclusion doesn't start with recruitment goals, but rather relationships. In the latestSite Landscape Surveyfrom the Society for Clinical Research Sites (SCRS),[...]

Translational Research: Turning Scientific Discovery Into Real-World Impact

Apr 8th, 2025 in Glossary

Translational research plays a vital role in modern medicine by moving discoveries made in the lab into the clinic, where they can directly benefit patients. As a bridge between scientific innovation and real-world healthcare, translational research shortens the time it takes[...]

How the Right Site Supports Efficient Clinical Trial Start-Up Activities

Apr 1st, 2025 in Glossary

Selecting the right research site is one of the most important decisions in a clinical trial startup. A well-chosen site does more than just provide a location—it serves as a strategic link to a partnership that streamlines operations, expedites approvals, and keeps patient[...]

How eRegulatory Systems Support Clinical Trials

Mar 19th, 2025 in Glossary

As clinical research evolves, so do the tools and technologies that support it. That includes eRegulatory systems (also known as electronic trial master file or eTMF), which offer cloud-based solutions that enhance document management, ensure regulatory compliance, and improve[...]

Why Clinical Trial Budgeting & Project Management Go Hand-In-Hand

Feb 25th, 2025 in Glossary

Successful clinical trials rely on detailed budgeting and strong project management for financial sustainability, regulatory compliance, and operational efficiency. Sponsors and research sites must account for fixed and variable costs while maintaining flexibility to adapt to[...]

Clinical Trial Performance Metrics: A Strategic Approach to Success

Feb 18th, 2025 in Glossary

A clinical trial’s success hinges on more than recruitment numbers and meeting deadlines—it’s about understanding and optimizing every part of the process. Clinical trial performance metrics offer the insight needed to achieve these goals. By tracking and analyzing key[...]

Choosing the Right Vaccine CRO Services To Accelerate Development

Feb 13th, 2025 in Vaccines

There’s growing demand for vaccine CRO services, with numerous factors at play. The pandemic highlighted the need for rapid vaccine development. Platforms like mRNA, which revolutionized COVID-19 vaccines, are now being tested for other conditions. Initiatives have pushed for[...]

Patient Retention in Clinical Trials: Overcoming Challenges To Drive Success

Feb 4th, 2025 in Glossary

Patient retention is vital to the success of clinical trials, yet it doesn’t always receive the same level of attention as patient enrollment. For sponsors and contract research organizations (CROs) to meet their trial goals and stay on schedule, they need to hold onto the[...]

Best Practices to Meet 21 CFR Part 11 Audit Trail Requirements

Jan 21st, 2025 in Glossary

Compliance with 21 CFR Part 11 requires maintaining secure, computer-generated audit trails that document all modifications to electronic records. These trails supportdata integrity by recording what changes were made, who made them, and when. Proper security measures,[...]

AI in Clinical Trials: Can It Move the Needle Faster?

Jan 7th, 2025 in Trends

Clinical trials have a median cost of $19 million, with the average cost exceeding $41 million per trial. Considering the majority of trials face delays—and these can cost anywhere from hundreds of thousands to millions of dollars per day—there’s no shortage of incentive to[...]

Phases of Vaccine Trials: A Comprehensive Breakdown

Dec 17th, 2024 in Glossary

Vaccine development is a detailed process, broken into clearly defined phases. Each phase addresses specific questions about the safety, efficacy, and scalability of new vaccines, with the ultimate goal of protecting public health. Preclinical Vaccine Research Objectives: [...]

How the Clinical Research Staffing Model Is Evolving

Dec 11th, 2024 in Trends

Traditionally, many professionals fell into clinical research by chance, starting at entry-level positions in the field and gradually progressing through the ranks. Now, we’re seeing a shift to a more intentional approach, where four-year bachelor degrees in clinical research[...]

CTMS vs. eTMF: Why Understanding and Integrating These Systems Matters

Dec 5th, 2024 in Glossary

In clinical trials, efficient operations and detailed documentation drive success. A clinical trial management system (CTMS) and an electronic trial master file (eTMF) are two foundational elements, each with distinct purposes. CTMS focuses on operational oversight, while eTMF[...]

The Impact of IRT Data Integration on Clinical Trials

Dec 3rd, 2024 in Glossary

Interactive response technology (IRT) systems have changed the way clinical trials are managed. By automating key processes like patient randomization, drug supply management, and data collection, IRT streamlines operations and ensures precision. The integration of IRT systems[...]

Clinical Trial Compliance: Maintaining Ethical Standards and Participant Safety

Nov 26th, 2024 in Glossary

Compliance in clinical trials is fundamental to protecting the rights of research participants, preserving data integrity, and advancing medical knowledge. To achieve this, trials must adhere to regulatory requirements as well as trial-specific protocols that outline precise[...]

How Electronic Data Capture Is Shaping the Future of Clinical Research

Nov 13th, 2024 in Glossary

*In clinical research, case report forms (CRFs) and electronic data capture (EDC) systems are often used interchangeably. In the context of this article, CRFs refer to the forms that collect the required clinical data for analysis—the actual data points. The EDC system is the[...]

3 Good Reasons To Diversify Your Clinical Research Site Network

Nov 7th, 2024 in Good Clinical Practice

Over the past five years, the clinical research industry has experienced a surge in merger and acquisition (M&A) activity, driven by the need for scale, technological integration, and diversification of capabilities. Companies like Centricity Research and The IMA Group have[...]

Clinical Trial Project Management: From Recruitment to Regulatory Compliance

Oct 29th, 2024 in Glossary

Effective clinical trial project management supports smooth trial operations by coordinating regulatory compliance, data management, and stakeholder engagement. It's a matter of managing timelines, controlling budgets, and overseeing recruitment strategies to maintain trial[...]

What Causes Delays in Vaccine Trials?

Oct 22nd, 2024 in Vaccines

Vaccine trials are critical to public health, but they are also complex and highly scrutinized. When delays occur, they can have far-reaching consequences, from prolonged time-to-market to increased costs. If your vaccine trial has gone “off the rails” so to speak, it’s crucial[...]

Lyme Disease in Ohio: Causes and Clinical Trials

Oct 11th, 2024 in

Lyme disease is on the rise in Ohio and its border states due to an increase in the population of adult blacklegged ticks, also known as deer ticks. While antibiotics can treat the infection, Lyme disease can still cause both short-term symptoms and potentially lingering[...]

Clinical Trial Data Management Best Practices For Sponsors and CROs

Oct 2nd, 2024 in Glossary

Effectively managing clinical trial data is crucial for maintaining research integrity and compliance. Researchers typically use clinical trial management systems (CTMS) to orchestrate trial operations and integrate with electronic data capture (EDC) for centralized data[...]

Empowering Acceptance: Supporting Alopecia Awareness Month

Sep 12th, 2024 in Dermatology

September is Alopecia Awareness Month, an opportunity to educate others about alopecia areata, a common autoimmune condition that causes hair loss on the scalp, face, and body. As we deepen our understanding of this condition, we can support and uplift those affected, helping to[...]

What Are the Benefits of a Clinical Trial Management System?

Sep 5th, 2024 in Glossary

A clinical trial management system (CTMS)—also referred to as clinical trial management software—streamlines clinical trial operations from startup to closeout. It centralizes protocols, subjects/patients, and financials, enhancing efficiency and oversight. Clinical research[...]

Good Clinical Practice Principles for Sponsors and Investigators

Aug 20th, 2024 in Good Clinical Practice

Good Clinical Practice (GCP) serves as the foundation for maintaining patient safety and data integrity, providing a framework that safeguards patients while facilitating scientific advancements. In this post, we’ll highlight good clinical practice principles and examine recent[...]

10 Milestones in The History Of Vaccines

Aug 10th, 2024 in Vaccines

August is National Immunization Awareness Month, a time to reflect on the importance of vaccinations and ongoing vaccine research. Vaccines are among the most important weapons in the public health arsenal. They have significantly reduced the occurrence of preventable[...]

Trends in Pulmonary & Respiratory Medicine: Insights from Dr. Roy St. John

Jul 17th, 2024 in Pulmonary

With over three decades of experience and a distinguished career, Dr. St. John brings invaluable expertise to our research initiatives. We recently met with him to discuss the latest trends in pulmonary and respiratory medicine, including biologics, triple inhalers, and[...]

The Dynamics of Dermatology Clinical Trials: From New Therapies to Patient Enrollment

Jun 20th, 2024 in News

Dr. Michelle Chambers, a Remington-Davis (RDI) board certified dermatologist, has been involved in dermatological clinical research since the 1990s — she brought her expertise to Remington-Davis in 2019. We recently had the chance to sit down with Dr. Chambers and look at some[...]

Remington-Davis Welcomes Dr. Roy St. John to Its Physician Team

May 30th, 2024 in News

We are excited to announce the new addition to the Remington-Davis family: Dr. Roy St. John. He joins our team of expert board-certified physicians in the central Ohio region that represent over 20 therapeutic areas, including pulmonology. As a board-certified Pulmonary &[...]

Beyond Enrollment: How Site Selection Impacts Patient Retention in Clinical Trials

May 20th, 2024 in News

Patient recruitment is recognized as one of the biggest challenges in clinical research. But getting patients enrolled in clinical trials is just the first step — it then becomes a question of how to keep them engaged in the process. And as research shows, this is easier said[...]

eSource for Clinical Trials: Exploring Challenges & Opportunities

May 6th, 2024 in News

eSource — the electronic capture of clinical trial source data — first gained traction in the late 2000s as technologies like electronic health records (EHRs) and electronic patient diaries became more prevalent. Designed to replace the manual collection and entry of data, the[...]

Applying the Benefits of Decentralized Clinical Trials to Hybrid Trials

Apr 22nd, 2024 in News

The pandemic was a clear catalyst in the rise of decentralized clinical trials (DCTs). But it may come as a surprise to some that this shift from traditional clinical trials was already gaining momentum in the years prior, with advancements in technology. Telemedicine platforms,[...]

Advancements in Respiratory Medicine: An Interview With Dr. Edward Cordasco

Apr 15th, 2024 in News

Respiratory medicine is continuously evolving, with new advancements taking shape to support progress and better outcomes every day. We recently discussed some of these advancements with Dr. Edward Cordasco, a Remington-Davis (RDI) board-certified physician with over 36 years of[...]

Diversity in Clinical Trials: The Latest FDA Guidance

Feb 21st, 2024 in News

Diversity has always mattered in clinical trials and health care in general. As the National Institutes of Health (NIH) notes, “people may experience the same disease differently.” With a more diverse pool of clinical trial participants, researchers can better account for these[...]

Why Is It So Hard To Find Healthy Volunteers for Clinical Trials?

Jan 23rd, 2024 in News

Healthy volunteers are a cornerstone of successful clinical trials. Before medications or devices are given to patient groups with a specific condition, interventions on healthy volunteers set a baseline in the early stages of clinical research. These control groups ultimately[...]

Trends in Immunology Clinical Trials: An Interview With Dr. Ian Baird

Jan 17th, 2024 in News

The landscape of immunology clinical trials rarely stands still, from breakthroughs in scientific advancements to changing outlooks on trial dynamics and expectations. Dr. Ian Baird, a Remington-Davis (RDI) board-certified infectious disease physician who has conducted 262[...]

Two OSU nursing students take part in clinical trials that might help battle COVID-19

Jul 31st, 2020 in News

Here’s your chance to catch up on a story featuring two #OSUNursing students who #volunteered for a #clinicaltrial with #RemingtonDavis when they contracted #Covid_19. [...]

Remington-Davis launches dedicated COVID-19 research unit in Ohio

Jul 8th, 2020 in News

By Chris Newmarker | July 8, 2020 Clinical research outfit Remington-Davis recently announced that it has launched a dedicated 3,000 ft2 space in Columbus, Ohio for COVID-19 clinical trials. The space includes six private overnight rooms, patient lounge, dedicated laboratory,[...]